Nuvation Bio
Patents, Design & Utilities
Last updated:
List of all Nuvation Bio patents 30 in total
| Status | Patent |
|---|---|
Application | Utility: HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: CRYSTALLINE FORMS OF A CYCLIN-DEPENDENT KINASE INHIBITOR Filling date: 6 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: SUBSTITUTED 1,6-DIHYDROPYRIDINONES AND 1,2-DIHYDROISOQUINOLINONES AS BET INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Heterocyclic compounds as adenosine antagonists Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Heterocyclic compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Diarylhydantoin compounds and methods of use thereof Filling date: 6 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: 1,8-naphthyridinone compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors Filling date: 6 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: Heterocyclic compounds as kinase inhibitors Filling date: 6 Sep 2025 Issue date: 16 Nov 2021 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 15 Jul 2021 |
Grant | Utility: Pyrrole and pyrazole compounds and methods of use thereof Filling date: 6 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Heterocyclic compounds as adenosine antagonists Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS BET INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: ANTI-CANCER NUCLEAR HORMONE RECEPTOR-TARGETING COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Heterocyclic compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 20 Oct 2020 |
Application | Utility: HETEROCYCLIC COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 15 Oct 2020 |
Grant | Utility: 1,8-naphthyridinone compounds and uses thereof Filling date: 6 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: DIARYLHYDANTOIN COMPOUNDS AND METHODS OF USE THEREOF Filling date: 6 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS BET INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 May 2020 |
Showing 1 to 30 of 30 patents.